Livzon Pharma to Distribute Final Dividend of RMB1.43 per Share for FY2025

Bulletin Express03-24

Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.30 per 10 shares, equivalent to RMB1.43 per share, for the financial year ended 31 December 2025, according to the cash dividend announcement released on 24 March 2026.

The dividend is subject to shareholder approval, with the record date, ex-dividend date, payment date, exchange rate for Hong Kong dollar conversion and related withholding-tax arrangements yet to be announced.

Tricor Investor Services Limited will act as the share registrar, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

Livzon Pharma’s board currently comprises one executive director (Mr. Tang Yanggang), three non-executive directors, one employee representative director and four independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1130870363?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-24 21:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130870363","market":"us","top_or_hot":-1,"title":"Livzon Pharma to Distribute Final Dividend of RMB1.43 per Share for FY2025","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.30 per 10 shares, equivalent to RMB1.43 per share, for the financial year ended 31 December 2025, according to the cash dividend announcement released on 24 March 2026.</p>\n<p>The dividend is subject to shareholder approval, with the record date, ex-dividend date, payment date, exchange rate for Hong Kong dollar conversion and related withholding-tax arrangements yet to be announced.</p>\n<p>Tricor Investor Services Limited will act as the share registrar, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>Livzon Pharma’s board currently comprises one executive director (Mr. Tang Yanggang), three non-executive directors, one employee representative director and four independent non-executive directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma to Distribute Final Dividend of RMB1.43 per Share for FY2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma to Distribute Final Dividend of RMB1.43 per Share for FY2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-24 21:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.30 per 10 shares, equivalent to RMB1.43 per share, for the financial year ended 31 December 2025, according to the cash dividend announcement released on 24 March 2026.</p>\n<p>The dividend is subject to shareholder approval, with the record date, ex-dividend date, payment date, exchange rate for Hong Kong dollar conversion and related withholding-tax arrangements yet to be announced.</p>\n<p>Tricor Investor Services Limited will act as the share registrar, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.</p>\n<p>Livzon Pharma’s board currently comprises one executive director (Mr. Tang Yanggang), three non-executive directors, one employee representative director and four independent non-executive directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1130870363","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130870363","pubTimestamp":1774358519,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.30 per 10 shares, equivalent to RMB1.43 per share, for the financial year ended 31 December 2025,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药拟派发2025财年末期股息每股人民币1.43元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.30 per 10 shares, equivalent to RMB1.43 per share, for the financial year ended 31 December 2025, according to the cash dividend announcement released on 24 March 2026.\nThe dividend is subject to shareholder approval, with the record date, ex-dividend date, payment date, exchange rate for Hong Kong dollar conversion and related withholding-tax arrangements yet to be announced.\nTricor Investor Services Limited will act as the share registrar, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.\nLivzon Pharma’s board currently comprises one executive director (Mr. Tang Yanggang), three non-executive directors, one employee representative director and four independent non-executive directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1130870363","isCrawlerRequest":true}